WINTON GROUP Ltd Purchases Shares of 7,464 Cooper Companies, Inc. (The) (NYSE:COO)

WINTON GROUP Ltd acquired a new stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 7,464 shares of the medical device company’s stock, valued at approximately $1,787,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Schwab Charles Investment Management Inc. lifted its holdings in shares of Cooper Companies, Inc. (The) by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,686 shares of the medical device company’s stock worth $58,583,000 after buying an additional 13,004 shares during the period. Scout Investments Inc. lifted its holdings in shares of Cooper Companies, Inc. (The) by 29.3% in the 2nd quarter. Scout Investments Inc. now owns 116,320 shares of the medical device company’s stock worth $27,849,000 after buying an additional 26,370 shares during the period. Amalgamated Bank lifted its stake in shares of Cooper Companies, Inc. (The) by 27.0% during the 2nd quarter. Amalgamated Bank now owns 9,764 shares of the medical device company’s stock worth $2,338,000 after purchasing an additional 2,073 shares during the last quarter. Oak Ridge Investments LLC lifted its stake in shares of Cooper Companies, Inc. (The) by 36.0% during the 2nd quarter. Oak Ridge Investments LLC now owns 19,294 shares of the medical device company’s stock worth $4,619,000 after purchasing an additional 5,110 shares during the last quarter. Finally, Keybank National Association OH lifted its stake in shares of Cooper Companies, Inc. (The) by 18.4% during the 2nd quarter. Keybank National Association OH now owns 8,631 shares of the medical device company’s stock worth $2,066,000 after purchasing an additional 1,343 shares during the last quarter. Institutional investors own 96.04% of the company’s stock.

Shares of Cooper Companies, Inc. (COO) traded up 1.67% on Friday, hitting $244.43. The stock had a trading volume of 328,737 shares. The company has a market cap of $11.96 billion, a price-to-earnings ratio of 35.05 and a beta of 0.54. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39. The stock has a 50 day moving average price of $239.84 and a 200-day moving average price of $232.96.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. The company had revenue of $556.00 million during the quarter, compared to analyst estimates of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter last year, the business posted $2.30 EPS. On average, equities analysts expect that Cooper Companies, Inc. will post $9.73 earnings per share for the current year.

A number of equities research analysts recently weighed in on the company. Jefferies Group LLC restated a “buy” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Thursday, July 6th. J P Morgan Chase & Co restated a “hold” rating and set a $235.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Oppenheimer Holdings, Inc. restated a “hold” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Robert W. Baird upped their price objective on Cooper Companies, Inc. (The) from $239.00 to $251.00 and gave the stock an “outperform” rating in a research note on Thursday, July 6th. Finally, Zacks Investment Research lowered Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Cooper Companies, Inc. (The) has an average rating of “Buy” and a consensus target price of $261.11.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This report was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/10/28/7464-shares-in-cooper-companies-inc-the-coo-purchased-by-winton-group-ltd.html.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply